Clinical trial
rhTSH, Radioiodine Uptake and Goiter Reduction Following 131I Therapy in…
NCT00275171 · Steen Bonnema, Other · Completed
Key facts
| NCT number | NCT00275171 |
|---|---|
| Title | rhTSH, Radioiodine Uptake and Goiter Reduction Following 131I Therapy in Patients With Benign Nontoxic Nodular Goiter |
| Official title | The Effect of 0.1 mg Recombinant Human Thyrotropin (rhTSH) on Thyroid Radioiodine-uptake and the Degree of Goiter Reduction Following 131I-therapy, in Patients With Benign Non-toxic Nodular Goiter. A Randomized, Double-blind, Placebo-controlled Trial. |
| Lead sponsor | Steen Bonnema, Other |
| Status | Completed |
| Phase | Phase 2 |
| Study type | Interventional |
| Conditions | Nodular Goiter |
| Intervention type | Drug, Other |
| Interventions | Recombinant human thyrotropin (Thyrogen), recombinant human TSH, isotonic saline = placebo |
| Enrollment | 90 |
| Start date | Feb 1, 2006 |
| Primary completion | Apr 1, 2009 |
| Completion | Sep 1, 2009 |
| First posted | Jan 11, 2006 |
| Last update posted | Dec 4, 2013 |
| Countries | Denmark |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: